a7nAChR |
alpha-7 nicotinic acetylcholine receptor |
ABCA1 |
ATP binding cassette A1 |
ABCB1 |
ATP-binding cassette sub-family B member 1 |
ACE |
Angiotensin-converting enzyme |
AD |
Alzheimer’s disease |
AJ |
Adherent-junction |
ApoE |
Apolipoprotein E |
APP |
Amyloid precursor protein |
AQP4 |
Aquaporin-4 water channels |
ARB |
Angiotensin receptor blocker |
AT1 |
Angiotensin II type 1 receptor |
Aβ |
Amyloid β-peptide |
BACE1 |
Beta-site APP cleaving enzyme 1 |
BBB |
Blood-brain barrier |
BDNF |
Brain-derived neurotrophic factor |
BEC |
Brain endothelial cell |
b-FGF |
Basic fibroblast growth factor |
C.p. |
Clinical phase |
Cx |
Complement factors |
CAA |
Cerebral amyloid angiopathy |
CBF |
Cerebral blood flow |
CCB |
Calcium channel blocker |
CNS |
Central nervous system |
COX-2 |
Cyclooxygenase-2 |
CR |
Complement receptor |
CSF |
Cerebrospinal fluid |
DDS |
Drug delivery systems |
eNOS |
Endothelial nitric oxide synthase |
fAβ |
Fibrillar Aβ |
Fc γ R |
Fc γ receptor |
Fyn |
Proto-oncogene tyrosine-protein kinase Fyn |
GDNF |
Glial cell-derived neurotrophic factor |
GLP-1 |
Glucagon-like peptide 1 |
GLUT |
Glucose transporter |
GSK3β |
Glycogen synthase kinase 3β |
HCHWA-D |
Hereditary cerebral hemorrhage with amyloidosis-Dutch type |
HImAb |
Human insulin mAb |
HMG-CoA |
3-Hydroxy-3-methylglutaryl-CoA |
HSA |
Human serum albumin |
IEL |
Internal elastic lamina |
IGF-1 |
Insulin-like growth factor 1 |
IgG |
Immunoglobulin G |
IL-1α |
Interleukin-1 alpha |
IL-1 β |
Interleukin-1 beta |
IL-1R1 |
Interleukin 1 receptor type 1 |
iNos |
inducible nitric oxide synthase |
IR |
Insulin receptor |
ISF |
Interstitial fluid |
LAMs |
Leukocyte adhesion molecules |
LRP1 |
Low-density lipoprotein receptor-related protein 1 |
mAb |
Monoclonal antibody |
mAβ |
Monomeric Aβ |
MEOX2 |
Mesenchyme homeobox gene 2 |
MMP |
Matrix metalloproteinase |
MTJ |
Molecular Trojan horse |
NF-kB |
Nuclear factor-κB |
NFT |
Neurofibrillary tangle |
NGF |
Nerve growth factor |
NMDAR |
N-Methyl-d-aspartate receptors |
NP |
Neuritic plaque |
NSAIDs |
Non-steroidal anti-inflammatory drugs |
NVU |
Neurovascular unit |
oAβ |
Oligomeric Aβ |
p47PHOX |
Neutrophil cytosol factor 1 |
Pcp |
Preclinical phase |
PDGF-B |
Platelet-derived growth factor subunit B |
PDGFRβ |
Platelet-derived growth factor receptor-β |
PGE2 |
Prostaglandin-E2 |
P-gp |
P-glycoprotein |
PHF |
Paired helical filament |
PI3K |
Phosphatidylinositol 3-kinase |
PVMs |
Perivascular macrophages |
RAGE |
Receptor for advanced glycation endproducts |
RMT |
Receptor-mediated transcytosis |
ROS |
Reactive oxygen species |
sAPPα |
Secreted ectodomain APP alpha |
SAS |
Subarachnoid space |
SEC-R |
Serpin-enzyme complex receptor |
sLRP |
Soluble low-density lipoprotein receptor-related protein |
SMC |
Smooth muscle cell |
SRA |
Class A scavenger receptor |
SRB2 |
Scavenger receptor class B member 2 |
SREBP2 |
Sterol response element-binding protein 2 |
SRF |
Serum response factor |
TfR |
Human transferrin receptor |
TGF-β |
Transforming growth factor-beta |
TJ |
Tight-junction |
TLR |
Toll-like receptor |
TNF-α |
Tumoral necrosis factor-α |
TNFR |
Tumoral necrosis factor receptor |
TREM2 |
Triggering receptor expressed on myeloid cells 2 |
VEGF |
Vascular endothelial growth factor |
ZO-1 |
Zonula occludens-1 |
γ-PPAR |
Peroxisome proliferator-activated receptor-γ |